Homocysteine: An activity marker in Behçet's disease?

Journal of Dermatological Science

Volumn 45, Issue 2, 2007, Pages 121-126

  Sarican, Tuncay ^a   Ayabakan, Hatice ^a   Turkmen, Sembol ^a   Kalaslioglu, Vesile ^a   Baran, Fehmi ^a   Yenice, Necati ^a  

^a OKMEYDANI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Beh et's disease; Homocysteine

Indexed keywords

HOMOCYSTEINE;

ADOLESCENT; ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BEHCET DISEASE; BLOOD SAMPLING; CHEMOLUMINESCENCE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; THROMBOGENESIS;

ACUTE DISEASE; ADULT; BEHCET SYNDROME; BIOLOGICAL MARKERS; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 33846238634     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2006.11.008     Document Type: Article

References (41)

1. Behçet H. Uber residivierende aphthose, durch ein virus verursachte geschwure am mund, am auge und an den genitalien. Dermatol Wochenschr 105 (1937) 1152-1157
2. Sakane T., Takeno M., and Suzuki N. Inaba G: Behçet's disease. N Engl J Med 341 (1999) 1284-1291
3. Lakhanpal S., Tani K., Lie J.T., Katoh H., Ishigatsubo Y., et al. Pathologic features of Behçet's syndrom: a review of Japanese autopsy registry data. Hum Pathol 16 (1985) 790-795
4. Ozoran K., Dugun N., Gurlar A., Tutkak H., and Tokgoz G. Plasma von Willebrand factor, tissue plasminogen activator, plasminogen activator inhibitor, and antithrombin III levels in Behçet's disease. Scand J Rheumatol 24 (1995) 376-382
5. Hampton K.K., Chamberlain M.A., Menon D.K., and Davies J.A. Coagulation and fibrinolytic activity in Behçet's disease. Thromb Haemost 66 (1991) 292-294
6. Mege J.L., Dilsen N., Sanguedolce V., et al. Overproduction of monocyte derived tumor necrosis factor alpha interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease: a comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 20 (1993) 1544-1549
7. Niwa Y., Miyake S., Sakane T., Shingu M., and Yokoyama M. Auto-oxidative damage in Behçet's disease endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils. Clin Exp Immunol 49 (1982) 247-255
8. Freitas J.P., Filipe P., Yousefi A., Emerit I., et al. Oxidative stress in Adamantiades-Behçet's disease. Dermatology 197 (1998) 343-348
9. Sandikci R., Turkmen S., Guvenen G., Ayabakan H., et al. Lipid peroxidation and antioxidant defence system in patients with active or inactive Behçet's disease. Acta Derm Venerol 83 (2003) 342-346
10. Stampfer M.J., Malinow M.R., Willet W.C., Newcomer L.M., Upson B., et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 268 (1992) 877-881
11. Graham I.M., Daly L.E., Refsum H.M., Robinson K., Brattstrom L.E., et al. Plasma homocysteine as a risk factor for vascular disease: the European Concerted Action Project. JAMA 277 (1997) 1775-1781
12. Nygard O., Nordrehaug J.E., Refsum H., Ueland P.M., Farstad M., et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337 (1997) 230-236
13. Chambers J.C., Obeid O.A., Refsum H., Ueland P., Hackett D., et al. Plasma homocysteine concentrations and risk of coronary artery disease in UK Indian Asian and European men. Lancet 355 (2000) 523-527
14. Welch G.N., and Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 338 (1998) 1042-1050
15. Hoogeven E.K., Kostense P.J., Beks P.J., et al. Hyperhomocysteinaemia is associated with an increased risk of cardiovascular disease, espeially in non-insulin dependent diabetes mellitus: a population-based study. Arterioscler Thromb Vasc Biol 18 (1998) 133-138
16. Glueck C.J., Shaw P., Lang J.E., Tracy T., et al. Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients. Am J Cardiol 75 (1995) 132-136
17. Chaureau P., Chadefoux B., Coude M., et al. Increased plasma homocysteine concentration in patİents with chronic renal failure. Miner Electrolyte Metab 18 (1992) 196-198
18. Ueland P.M., and Refsum H. Plasma homocysteine, a risk factor for premature vascular disease. Plasma levels in healthy persons; during pathologic conditions and drug therapy. Nord Med 104 (1989) 293-298
19. Cattaneo M., Vecchi M., Zighetti M.L., et al. High prevalance of hyperhomocysteinaemia in patients with inflammatory bowel disease: a pathogenic link with thromboembolic complications?. Thromb Haemost 80 (1998) 542-545
20. Chambers J.C., McGregor A., Jean Marie J., Obeid O.A., and Kooner J.S. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia, an effect reversible with vitamin C therapy. Circulation 99 (1999) 1156-1160
21. Chambers J.C., Obeid O.A., and Kooner J.S. Physiological increments in plasma homocysteine induce vascular endothelial dysfunction in normal human subjects. Arterioscler Thromb Vasc Biol 19 (1999) 2922-2927
22. Bellamy M.F., McDowell I.F., Ramsey M.W., Brownlee M., et al. Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults. Circulation 98 (1998) 1848-1852
23. Kanani P.M., Sinkey C.A., Browning R.L., Allaman M., Knapp H.R., and Haynes W.G. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. Circulation 100 (1999) 1161-1168
24. Aksu K., Turgan N., Oksel F., Keser G., et al. Hyperhomocysteinaemia in Behçet's disease. Rheumatol 40 (2001) 687-690
25. Er H., Evereklioglu C., Cumurcu T., Turkoz Y., et al. Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behçet's disease. Br J Ophthalmol 86 (2002) 653-657
26. International Study Group for Behçet's disease. Criteria for diagnosis of Behçet's disease. Lancet 335 (1990) 1078-1080
27. Vine A.K. Hyperhomocysteinemia: a risk factor for central retinal vein occlusin. Am J Ophtalmol 129 (2000) 640-644
28. Masaki T., and Yanagisawa M. Endothelins Esseys Biochem 27 (1992) 79-89
29. Chambers J.C., Haskard D.O., and Kooner J.S. Vascular endothelial function and oxidative stress mechanisms in patients with Behçet's syndrome. J Am Coll Cardiol 37 (2001) 517-520
30. Lie J.T. Vascular involvement in Behçet's disease: arterial and venous vessels of all sizes. J Rheumatol 19 (1992) 341-343
31. Ghate J.V., and Jorizzo J.L. Behçets disease and complex aphthosis. J Am Acad Dermatol 40 (1999) 1-18
32. Hankey G.J., and Eilkelboom J.W. Homocysteine and vascular disease. Lancet 354 (1999) 407-413
33. Cahill M., Karabatzaki M., Meleady R., et al. Raised plasma homocysteine as a risk factor for retinal vasclar occlusive disease. Br J Ophthalmol 84 (2000) 154-157
34. Wald N.J., Watt H.C., Law M.R., et al. Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention. Arch Intern Med 158 (1998) 862-867
35. Woo K.S., Chook P., Lolin Y.I., et al. Hyperhomocysteinaemia is a risk factor for arterial endothelial dysfunction in humans. Circulation 96 (1997) 2542-2544
36. Turgan N., Boydak B., Habif S., et al. Plasma homocysteine levels in acute coronary syndromes. Jpn Herat J 40 (1999) 729-736
37. Kawasaki A., Purvin V.A., and Burget R.A. Hyperhomocycteinaemia in young patients with non-arteritic anterior ischaemic optic neuropathy. Br J Ophthalmol 83 (1999) 1287-1290
38. Wenzler E.M., Rademakers A.J., Boers G.H., et al. Hyperhomocysteinaemia in retinal artery and retinal vein occlusion. Am J Ophthalmol 115 (1993) 162-167
39. Finkelstein J.D. The metabolism of homocysteine: pathways and regulation. Eur J Pediatr 157 (1998) 40-44
40. Verity D.H., Vaughan R.W., Madanat W., et al. Factor V Leiden mutation is associated with ocular involvement in Behçet's disease. Am J Opthalmol 128 (1999) 352-356
41. D'Angelo A., and Selhub J. Homocysteine and thrombotic disease. Blood 90 (1997) 1-11